TNF and melanoma: Figure 5D shows that in spite of inter‐tumor heterogeneity, the treatment with BRIRi altered, in all four BMMC lines, the expression of genes belonging to three signaling pathways: the TNF signaling pathway, the pathway regulating pluripotency of stem cells, and the apoptotic pathway, which were commonly overrepresented in all four melanomas.